Effective immediately, this Advisory Notice supersedes CME Group Market Regulation Advisory Notice RA1703-5 from April 10, 2017. It is being issued based on the CFTC Division of Market Oversight’s no-action relief from certain position aggregation requirements under Commission Regulation 150.4 issued on August 10, 2017, pursuant to CFTC Letter No. 17-37
Click HERE to view the full advisory.